Oral Presentation: OP34: VARSITY: A Double-Blind, Double-Dummy, Randomised, Controlled Trial of Vedolizumab Versus Adalimumab in Patients With Active Ulcerative ColitisScientific Programme
2019
Oral Presentation: OP37: Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFIScientific Programme
2019
Oral Presentation: OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitisScientific Programme
2019
Outcomes from the ECCO Fellowship 2018: Monocyte-derived macrophages as crucial players in the resolution of inflammation and tissue repair in Inflammatory Bowel DiseaseScientific Programme
2019
Outcomes from the ECCO Fellowship 2018: Role of TNF-inducible gene-6 (TSG-6) in fistulising Crohn's DiseaseScientific Programme
2019
Outcomes from the ECCO Pioneer Award 2017: Faecal transplantation using a novel conditioning method for donor and recipient in mild to moderate treatment refractory colitis in Inflammatory Bowel DiseaseScientific Programme
2019
Outcomes of first admission for acute severe ulcerative colitis over a decade in EnglandJCC Podcast
2019
Outcomes of the ECCO-IOIBD Fellowship 2018 Deciphering the gut-specific B cell response in Inflammatory Bowel DiseaseScientific Programme
2019
Patient perspectives of guidelines - why should patients be involved1st Guideline Methodology and GRADE Workshop
2019